PROXY STATEMENT

Company

TENAX THERAPEUTICS, INC.

Filed

April 19, 2019

Period of Report

June 13, 2019

Accession Number

0001654954-19-004596

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →